Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Fluorenes"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 218
Tytuł:
Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana.
Autorzy:
Mawuli MA; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana. .; Department of Pathology, University of Ghana Medical School, College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana. .
Amoah LE; Department of Immunology, Noguchi Memorial Institute for Medical Research College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
Cui L; Department of Internal Medicine, University of South Florida, 3720 Spectrum Blvd, Tampa, FL, 33612, USA.
Quashie NB; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana.; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.; Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.
Afrane YA; Department of Medical Microbiology, University of Ghana Medical School College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2024 Feb 05; Vol. 23 (1), pp. 40. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria, Falciparum*/drug therapy
Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Ghana ; Drug Combinations ; Artemether/therapeutic use ; Recurrence ; Parasitemia/drug therapy ; Ethanolamines/therapeutic use ; Fluorenes/therapeutic use ; Plasmodium falciparum/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of pyronaridine-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial.
Autorzy:
Falade CO; Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria. .; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria. .
Orimadegun AE; Institute of Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olusola FI; Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Michael OS; Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Anjorin OE; Department of Accident and Emergency, Obafemi Awolowo University Teaching, Hospital, Ile-Ife, Nigeria.
Funwei RI; Department of Pharmacology, Babcock University, Ilisan, Remo, Ogun State, Nigeria.
Adedapo AD; Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olusanya AL; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Orimadegun BE; Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Mokuolu OA; Department of Paediatrics, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2023 May 13; Vol. 22 (1), pp. 154. Date of Electronic Publication: 2023 May 13.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antimalarials*/adverse effects
Artemisinins*/adverse effects
Malaria, Falciparum*/drug therapy
Humans ; Child ; Male ; Infant ; Female ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Nigeria ; Retrospective Studies ; Artemether/therapeutic use ; Drug Combinations ; Ethanolamines/therapeutic use ; Treatment Outcome ; Fluorenes/adverse effects
SCR Disease Name:
Acute malaria
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Autorzy:
Nyangulu W; Dignitas International, Zomba, Malawi.; Public Health and Nutrition Research Group, Kamuzu University of Health Sciences, Mangochi, Malawi.
Mungwira RG; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Divala TH; Dignitas International, Zomba, Malawi.
Nampota-Nkomba N; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Nyirenda OM; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.
Buchwald AG; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA.
Miller J; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA.
Earland DE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA.
Adams M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA.
Plowe CV; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA.
Taylor TE; Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi.; Michigan State University, East Lansing, USA.
Mallewa JE; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.
van Oosterhout JJ; Dignitas International, Zomba, Malawi.; Partners in Hope, Lilongwe Malawi and David Geffen School of Medicine, University of California, Los Angeles, USA.
Parikh S; Yale School of Public Health, New Haven, USA.
Laurens MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA.
Laufer MK; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD, 21201, USA. .
Pokaż więcej
Corporate Authors:
TSCQ Study Team
Źródło:
Malaria journal [Malar J] 2023 Jan 27; Vol. 22 (1), pp. 32. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria*/drug therapy
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/prevention & control
HIV Infections*/drug therapy
Humans ; Adult ; Malawi ; Artemether/therapeutic use ; Drug Combinations ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Lumefantrine/therapeutic use ; Treatment Outcome ; Ethanolamines/therapeutic use ; Fluorenes/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia.
Autorzy:
Gubae K; Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Mohammed H; Malaria and Other Parasitological and Entomological Research Team, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Sime H; Malaria and Other Parasitological and Entomological Research Team, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Hailgiorgis H; Malaria and Other Parasitological and Entomological Research Team, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Mare AK; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Gidey B; Malaria and Other Parasitological and Entomological Research Team, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Haile M; Ethiopian Ministry of Health, Addis Ababa, Ethiopia.
Assefa G; Ethiopian Ministry of Health, Addis Ababa, Ethiopia.
Bekele W; World Health Organization, Addis Ababa, Ethiopia.
Tasew G; Malaria and Other Parasitological and Entomological Research Team, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Abay SM; Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. .
Assefa A; Malaria and Other Parasitological and Entomological Research Team, Bacterial, Parasitic and Zoonotic Diseases Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.; Institute of Infectious Disease and Global Health, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2023 Jan 07; Vol. 22 (1), pp. 9. Date of Electronic Publication: 2023 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials*/adverse effects
Artemisinins*/adverse effects
Malaria, Falciparum*/epidemiology
Humans ; Infant ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Ethiopia/epidemiology ; Artemether/therapeutic use ; Plasmodium falciparum ; Drug Combinations ; Fluorenes/adverse effects ; Treatment Outcome ; Ethanolamines/adverse effects ; Fever/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya.
Autorzy:
Obonyo CO; Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya. .
Ogutu BR; Centre for Clinical Research, Kenya Medical Research Institute, P.O. Box 20778, Nairobi, Kenya.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2022 Jun 21; Vol. 21 (1), pp. 198. Date of Electronic Publication: 2022 Jun 21.
Typ publikacji:
Letter
MeSH Terms:
Antimalarials*/therapeutic use
Malaria, Falciparum*/drug therapy
Artemether/therapeutic use ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Clindamycin/therapeutic use ; Drug Combinations ; Ethanolamines/therapeutic use ; Fluorenes/therapeutic use ; Humans ; Kenya ; Quinine/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs.
Autorzy:
Krishna S; Centre for Diagnostics and Antimicrobial Resistance, Institute for Infection and Immunity, St George's University of London, London, UK.; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.
Kremsner PG; Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany. .; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2022 Jun 20; Vol. 21 (1), pp. 194. Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Letter
MeSH Terms:
Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria*/drug therapy
Malaria, Falciparum*/drug therapy
Drug Combinations ; Ethanolamines/therapeutic use ; Fluorenes/therapeutic use ; Humans ; Quinine/therapeutic use ; Treatment Outcome
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
Autorzy:
Mutagonda RF; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania. .
Kamuhabwa AAR; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania.
Minzi OMS; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. Box 65013, Dar es Salaam, Tanzania.
Massawe SN; Department of Obstetrics and Gynaecology, School of Medicine, Muhimbili University of Allied Sciences, P.O Box 65013, Dar es Salaam, Tanzania.
Asghar M; Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Solna, 171 76, Stockholm, Sweden.
Homann MV; Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Solna, 171 76, Stockholm, Sweden.
Färnert A; Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Solna, 171 76, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Aklillu E; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 77, Stockholm, Sweden.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2017 Jul 03; Vol. 16 (1), pp. 267. Date of Electronic Publication: 2017 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials/*pharmacokinetics
Ethanolamines/*pharmacokinetics
Fluorenes/*pharmacokinetics
Malaria, Falciparum/*drug therapy
Pregnancy Complications, Parasitic/*drug therapy
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics ; Adolescent ; Adult ; Alleles ; Antimalarials/blood ; Antimalarials/therapeutic use ; Aryl Hydrocarbon Hydroxylases/genetics ; Cohort Studies ; Cytochrome P-450 CYP2B6/genetics ; Cytochrome P-450 CYP3A/genetics ; Cytochrome P450 Family 2/genetics ; Ethanolamines/blood ; Ethanolamines/therapeutic use ; Female ; Fluorenes/blood ; Fluorenes/therapeutic use ; Gene Frequency ; Genotype ; Haplotypes ; Humans ; Lumefantrine ; Malaria, Falciparum/genetics ; Malaria, Falciparum/metabolism ; Pharmacogenetics ; Pregnancy ; Pregnancy Complications, Parasitic/genetics ; Pregnancy Complications, Parasitic/metabolism ; Pregnancy Trimester, Second ; Pregnancy Trimester, Third ; Prospective Studies ; Steroid Hydroxylases/genetics ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.
Autorzy:
Moore BR; School of Pharmacy, Curtin University of Technology, Perth, WA, Australia.; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.
Davis WA; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.
Clarke PM; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Robinson LJ; Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.; Burnet Institute, Parkville, Melbourne, VIC, Australia.; Division of Population Health and Immunity, Walter and Eliza Hall Institute, Parkville, VIC, Australia.
Laman M; Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.
Davis TME; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2017 Oct 30; Vol. 16 (1), pp. 438. Date of Electronic Publication: 2017 Oct 30.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Cost-Benefit Analysis*
Antimalarials/*economics
Artemisinins/*economics
Ethanolamines/*economics
Fluorenes/*economics
Malaria, Falciparum/*economics
Malaria, Vivax/*economics
Naphthoquinones/*economics
Randomized Controlled Trials as Topic/*statistics & numerical data
Antimalarials/therapeutic use ; Artemether, Lumefantrine Drug Combination ; Artemisinins/therapeutic use ; Child, Preschool ; Drug Combinations ; Ethanolamines/therapeutic use ; Female ; Fluorenes/therapeutic use ; Humans ; Infant ; Malaria, Falciparum/drug therapy ; Malaria, Vivax/drug therapy ; Male ; Naphthoquinones/therapeutic use ; Papua New Guinea ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The drug transporter ABCB1 c.3435C>T SNP influences artemether-lumefantrine treatment outcome.
Autorzy:
Kiaco K; Unidade de Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal. .; Serviços de Saúde das Forças Armadas Angolanas, Estado Maior General das Forças Armadas, Luanda, Angola. .
Rodrigues AS; Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, Universidade Nova de Lisboa, Lisbon, Portugal.
do Rosário V; Unidade de Parasitologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Gil JP; Drug Resistance Unit, Division of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Lopes D; Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.; Center for Biodiversity, Functional and Integrative Genomics, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2017 Sep 21; Vol. 16 (1), pp. 383. Date of Electronic Publication: 2017 Sep 21.
Typ publikacji:
Journal Article
MeSH Terms:
Genotype*
Polymorphism, Single Nucleotide*
Antimalarials/*pharmacology
Artemisinins/*pharmacology
Ethanolamines/*pharmacology
Fluorenes/*pharmacology
Malaria/*drug therapy
ATP Binding Cassette Transporter, Subfamily B/genetics ; ATP Binding Cassette Transporter, Subfamily B/metabolism ; Angola ; Antimalarials/pharmacokinetics ; Artemether, Lumefantrine Drug Combination ; Artemisinins/pharmacokinetics ; Cytochrome P-450 CYP3A/genetics ; Cytochrome P-450 CYP3A/metabolism ; Drug Combinations ; Ethanolamines/pharmacokinetics ; Fluorenes/pharmacokinetics ; Humans ; Prevalence ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.
Autorzy:
Bharti PK; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India.
Shukla MM; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India.
Ringwald P; Global Malaria Programme World Health Organization, Geneva, Switzerland.
Krishna S; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India.
Singh PP; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India.
Yadav A; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India.
Mishra S; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India.
Gahlot U; Community Health Centre Ranapur, District Jhabua, Madhya Pradesh, India.
Malaiya JP; Community Health Centre Rajendragram, District Anuppur, Madhya Pradesh, India.
Kumar A; Community Health Centre Jaldega, District Simdega, Jharkhand, India.
Prasad S; Community Health Centre Bano, District Simdega, Jharkhand, India.
Baghel P; Community Health Centre Kilepal, District Bastar, Chhattisgarh, India.
Singh M; Satpura Bhawan, Bhopal, Madhya Pradesh, India.
Vadadi J; Indravati Bhawan, Raipur, Chhattisgarh, India.
Singh MP; National Institute of Malaria Research (NIMR) Field Station, Jabalpur, MP, India.
Bustos MD; World Health Organization, Country Office for Thailand, Bangkok, Thailand.
Ortega LI; Global Malaria Programme World Health Organization, Geneva, Switzerland.
Christophel EM; World Health Organization, Regional Office for South-East Asia, New Delhi, India.
Kashyotia SS; National Vector Borne Disease Control Programme (NVBDCP), New Delhi, India.
Sonal GS; National Vector Borne Disease Control Programme (NVBDCP), New Delhi, India.
Singh N; National Institute for Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh, 482003, India. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 Oct 13; Vol. 15 (1), pp. 498. Date of Electronic Publication: 2016 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antigens, Protozoan/genetics ; Antimalarials/adverse effects ; Artemether, Lumefantrine Drug Combination ; Artemisinins/adverse effects ; Child ; Child, Preschool ; Drug Combinations ; Drug-Related Side Effects and Adverse Reactions ; Ethanolamines/adverse effects ; Fluorenes/adverse effects ; Humans ; India ; Infant ; Merozoite Surface Protein 1/genetics ; Middle Aged ; Plasmodium falciparum/classification ; Plasmodium falciparum/genetics ; Plasmodium falciparum/isolation & purification ; Prospective Studies ; Protozoan Proteins/genetics ; Sequence Analysis, DNA ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal.
Autorzy:
Mbaye A; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal. .
Dieye B; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Ndiaye YD; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Bei AK; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA.
Muna A; Malaria Research Centre, Serrekunda, Gambia.
Deme AB; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Yade MS; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Diongue K; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Gaye A; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Ndiaye IM; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Ndiaye T; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Sy M; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Diallo MA; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Badiane AS; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Ndiaye M; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Seck MC; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Sy N; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.
Koita O; University of Bamako, Bamako, Mali.
Krogstad DJ; Tulane University, New Orleans, LA, USA.
Nwakanma D; Malaria Research Centre, Serrekunda, Gambia.
Ndiaye D; Laboratory of Parasitology/Mycology HALD, Cheikh Anta Diop University of Dakar, PO Box 5005, Dakar, Senegal.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, USA.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 Aug 25; Vol. 15 (1), pp. 433. Date of Electronic Publication: 2016 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Frequency*
Haplotypes*
Selection, Genetic*
Antimalarials/*pharmacology
Artemisinins/*pharmacology
Ethanolamines/*pharmacology
Fluorenes/*pharmacology
Multidrug Resistance-Associated Proteins/*genetics
Plasmodium falciparum/*drug effects
Adolescent ; Antimalarials/therapeutic use ; Artemether, Lumefantrine Drug Combination ; Artemisinins/therapeutic use ; Child ; Child, Preschool ; Drug Combinations ; Ethanolamines/therapeutic use ; Female ; Fluorenes/therapeutic use ; Genetics, Population ; Genotyping Techniques ; Humans ; Malaria, Falciparum/parasitology ; Male ; Plasmodium falciparum/classification ; Plasmodium falciparum/genetics ; Senegal ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
Autorzy:
Poirot E; Global Health Group, University of California San Francisco, San Francisco, CA, USA. .; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA. .
Soble A; Clinton Health Access Initiative, Mbabane, Swaziland.
Ntshalintshali N; Clinton Health Access Initiative, Mbabane, Swaziland.
Mwandemele A; University of Namibia, Windhoek, Namibia.
Mkhonta N; National Malaria Control Programme, Manzini, Swaziland.
Malambe C; National Malaria Control Programme, Manzini, Swaziland.
Vilakati S; National Malaria Control Programme, Manzini, Swaziland.
Pan S; Clinton Health Access Initiative, Mbabane, Swaziland.
Darteh S; International Center for AIDS Care and Treatment Programs, Mbabane, Swaziland.
Maphalala G; Swaziland Health Laboratory Services, Mbabane, Swaziland.
Brown J; Global Health Group, University of California San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Hwang J; Global Health Group, University of California San Francisco, San Francisco, CA, USA.; President's Malaria Initiative, Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pace C; Liverpool School of Tropical Medicine, Liverpool, UK.
Stergachis A; Departments of Pharmacy and Global Health, Schools of Pharmacy and Public Health, University of Washington, Seattle, USA.
Vittinghoff E; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Kunene S; National Malaria Control Programme, Manzini, Swaziland.
Gosling R; Global Health Group, University of California San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 Jul 22; Vol. 15 (1), pp. 384. Date of Electronic Publication: 2016 Jul 22.
Typ publikacji:
Journal Article
MeSH Terms:
Pharmacovigilance*
Antimalarials/*adverse effects
Artemisinins/*adverse effects
Ethanolamines/*adverse effects
Fluorenes/*adverse effects
Malaria, Falciparum/*drug therapy
Primaquine/*adverse effects
Product Surveillance, Postmarketing/*methods
Adolescent ; Adult ; Aged ; Antimalarials/administration & dosage ; Artemether, Lumefantrine Drug Combination ; Artemisinins/administration & dosage ; Child ; Child, Preschool ; Drug Combinations ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Eswatini ; Ethanolamines/administration & dosage ; Female ; Fluorenes/administration & dosage ; Humans ; Infant ; Male ; Middle Aged ; Pilot Projects ; Primaquine/administration & dosage ; Prospective Studies ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
Autorzy:
Mwaiswelo R; Department of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Ngasala BE; Department of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. .
Jovel I; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Gosling R; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Global Health Group, University of California San Francisco, San Francisco, CA, USA.
Premji Z; Aga Khan University Hospital, Nairobi, Kenya.
Poirot E; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Global Health Group, University of California San Francisco, San Francisco, CA, USA.
Mmbando BP; National Institute for Medical Research, Tanga Centre, Tanga, Tanzania.
Björkman A; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Mårtensson A; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 Jun 10; Vol. 15, pp. 316. Date of Electronic Publication: 2016 Jun 10.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Antimalarials/*adverse effects
Artemisinins/*adverse effects
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Ethanolamines/*adverse effects
Fluorenes/*adverse effects
Hemoglobins/*analysis
Malaria, Falciparum/*drug therapy
Primaquine/*adverse effects
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antimalarials/administration & dosage ; Artemether, Lumefantrine Drug Combination ; Artemisinins/administration & dosage ; Child ; Child, Preschool ; Drug Combinations ; Drug-Related Side Effects and Adverse Reactions/pathology ; Ethanolamines/administration & dosage ; Female ; Fluorenes/administration & dosage ; Genotyping Techniques ; Glucosephosphate Dehydrogenase/genetics ; Humans ; Infant ; Male ; Middle Aged ; Primaquine/administration & dosage ; Single-Blind Method ; Tanzania ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Autorzy:
Adeel AA; College of Medicine, King Saud University, Riyadh, Saudi Arabia. .
Elnour FA; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan.
Elmardi KA; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan.
Abd-Elmajid MB; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan.
Elhelo MM; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan.
Ali MS; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan.
Adam MA; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan.
Atta H; Malaria Control and Elimination, Division of Communicable Diseases Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Zamani G; Malaria Control and Elimination, Division of Communicable Diseases Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Warsame M; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Barrette A; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Mohammady HE; Naval Medical Research Unit-3, Cairo, Egypt.
Nada RA; Naval Medical Research Unit-3, Cairo, Egypt.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 May 21; Vol. 15 (1), pp. 285. Date of Electronic Publication: 2016 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance*
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*drug therapy
Plasmodium falciparum/*drug effects
Pyrimethamine/*therapeutic use
Sulfadoxine/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antimalarials/pharmacology ; Artemether, Lumefantrine Drug Combination ; Artemisinins/pharmacology ; Artesunate ; Child ; Child, Preschool ; Dihydropteroate Synthase/genetics ; Drug Combinations ; Ethanolamines/pharmacology ; Female ; Fluorenes/pharmacology ; Genetic Markers ; Genotype ; Humans ; Infant ; Infant, Newborn ; Malaria, Falciparum/parasitology ; Male ; Middle Aged ; Plasmodium falciparum/genetics ; Plasmodium falciparum/isolation & purification ; Pyrimethamine/pharmacology ; Sudan ; Sulfadoxine/pharmacology ; Tetrahydrofolate Dehydrogenase/genetics ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.
Autorzy:
Mutagonda RF; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. BOX 65013, Dar es Salaam, Tanzania. .
Kamuhabwa AA; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. BOX 65013, Dar es Salaam, Tanzania.
Minzi OM; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. BOX 65013, Dar es Salaam, Tanzania.
Massawe SN; Department of Obstetrics and Gynaecology, School of Medicine, Muhimbili University of Allied Sciences, P.O. BOX 65013, Dar es Salaam, Tanzania.
Maganda BA; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P.O. BOX 65013, Dar es Salaam, Tanzania.
Aklillu E; Department of Laboratory of Medicine, Division of Clinical Pharmacology, Karolinska Institutet, 141 86, Stockholm, Sweden.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 May 13; Vol. 15 (1), pp. 278. Date of Electronic Publication: 2016 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials/*pharmacokinetics
Artemisinins/*pharmacokinetics
Ethanolamines/*pharmacokinetics
Fluorenes/*pharmacokinetics
Malaria, Falciparum/*drug therapy
Malaria, Falciparum/*pathology
Plasma/*chemistry
Pregnancy Complications, Infectious/*drug therapy
Pregnancy Complications, Infectious/*pathology
Adolescent ; Adult ; Antimalarials/administration & dosage ; Artemether, Lumefantrine Drug Combination ; Artemisinins/administration & dosage ; Drug Combinations ; Ethanolamines/administration & dosage ; Female ; Fluorenes/administration & dosage ; Humans ; Pregnancy ; Prevalence ; Prospective Studies ; Recurrence ; Secondary Prevention ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Autorzy:
Paczkowski M; Malaria Branch, Division of Parasitic Diseases & Malaria, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop A06, Atlanta, GA, 30329-4027, USA. .
Mwandama D; Malaria Alert Centre, University of Malawi College of Medicine, Blantyre, Malawi.
Marthey D; United States Peace Corps, Washington, DC, USA.
Luka M; Malaria Alert Centre, University of Malawi College of Medicine, Blantyre, Malawi.
Makuta G; Malaria Alert Centre, University of Malawi College of Medicine, Blantyre, Malawi.
Sande J; National Malaria Control Programme, Ministry of Health, Lilongwe, Malawi.
Ali D; National Malaria Control Programme, Ministry of Health, Lilongwe, Malawi.
Troell P; US President's Malaria Initiative, Malaria Branch, Division of Parasitic Diseases and Malaria, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
Mathanga DP; Malaria Alert Centre, University of Malawi College of Medicine, Blantyre, Malawi.
Gutman J; Malaria Branch, Division of Parasitic Diseases & Malaria, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop A06, Atlanta, GA, 30329-4027, USA. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2016 Apr 26; Vol. 15, pp. 236. Date of Electronic Publication: 2016 Apr 26.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Amodiaquine/*therapeutic use
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*drug therapy
Amodiaquine/administration & dosage ; Amodiaquine/pharmacology ; Antimalarials/administration & dosage ; Antimalarials/pharmacology ; Artemether, Lumefantrine Drug Combination ; Artemisinins/administration & dosage ; Artemisinins/pharmacology ; Child, Preschool ; Drug Combinations ; Ethanolamines/administration & dosage ; Ethanolamines/pharmacology ; Female ; Fluorenes/administration & dosage ; Fluorenes/pharmacology ; Humans ; Infant ; Malawi ; Male ; Plasmodium falciparum/drug effects ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.
Autorzy:
Sondo P; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .
Derra K; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .
Diallo-Nakanabo S; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .
Tarnagda Z; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .
Zampa O; Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso. .
Kazienga A; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. kazienga_.
Valea I; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .; Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso. .
Sorgho H; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .
Owusu-Dabo E; Kumasi Center for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana. .
Ouedraogo JB; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .
Guiguemde TR; Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso. .
Tinto H; IRSS, Clinical Research Unit of Nanoro (CRUN), CMA Saint Camille of Nanoro, BP 218 Ouagadougou CMS 11, Nanoro, Burkina Faso. .; Centre Muraz of Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2015 Aug 20; Vol. 14, pp. 325. Date of Electronic Publication: 2015 Aug 20.
Typ publikacji:
Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Amodiaquine/*therapeutic use
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*drug therapy
Amodiaquine/adverse effects ; Antimalarials/adverse effects ; Artemether, Lumefantrine Drug Combination ; Artemisinins/adverse effects ; Burkina Faso/epidemiology ; Child ; Child, Preschool ; Drug Combinations ; Ethanolamines/adverse effects ; Female ; Fluorenes/adverse effects ; Humans ; Infant ; Infant, Newborn ; Kaplan-Meier Estimate ; Malaria, Falciparum/epidemiology ; Male ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia.
Autorzy:
Mekonnen SK; College of Health Siences, Jimma University, Jimma, Ethiopia. .; Armauer Hansen Research Institute, Addis Ababa, Ethiopia. .
Medhin G; Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia. .
Berhe N; Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia. nega_.; Ethiopia and Centre for Imported and Tropical Diseases, Oslo University Hospital-Ulleval, Oslo, Norway. nega_.
Clouse RM; Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA. .
Aseffa A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2015 Aug 15; Vol. 14, pp. 317. Date of Electronic Publication: 2015 Aug 15.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*drug therapy
Adolescent ; Adult ; Antimalarials/adverse effects ; Artemether, Lumefantrine Drug Combination ; Artemisinins/adverse effects ; Child ; Child, Preschool ; Drug Combinations ; Ethanolamines/adverse effects ; Ethiopia/epidemiology ; Female ; Fluorenes/adverse effects ; Humans ; Infant ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/epidemiology ; Male ; Microscopy ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study.
Autorzy:
Ebstie YA; School of Medicine, Addis Ababa University, PO Box 9086, Addis Ababa, Ethiopia. yeh_.
Zeynudin A; School of Medical Laboratory and Pathology, College of Public Health Medical Sciences, Jimma University, Jimma, Ethiopia. .
Belachew T; Department of Population and Family Health, College of Public Health Medical Sciences, Jimma University, Jimma, Ethiopia. tefera_.
Desalegn Z; School of Medicine, Addis Ababa University, PO Box 9086, Addis Ababa, Ethiopia. .
Suleman S; School of Pharmacy, College of Public Health Medical Sciences, Jimma University, Jimma, Ethiopia. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2015 Jun 05; Vol. 14, pp. 236. Date of Electronic Publication: 2015 Jun 05.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Ethanolamines/*therapeutic use
Fluorenes/*therapeutic use
Malaria, Falciparum/*drug therapy
Plasmodium falciparum/*drug effects
Adolescent ; Adult ; Aged ; Antimalarials/pharmacology ; Artemether, Lumefantrine Drug Combination ; Artemisinins/pharmacology ; Child ; Child, Preschool ; Cohort Studies ; Drug Combinations ; Ethanolamines/pharmacology ; Ethiopia ; Female ; Fluorenes/pharmacology ; Humans ; Male ; Middle Aged ; Parasitemia/drug therapy ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
Autorzy:
Tiono AB; Centre National de Recherche et de Formation sur le Paludisme, Ministère de la Santé, 01 BP 2208, Ouagadougou, Burkina Faso. .
Tinto H; Unité de Recherche Clinique de Nanoro (IRSS-CRUN), BP 218, Ouagadougou, CMS11, Burkina Faso. .
Alao MJ; Service de Pédiatrie, Hôpital de la Mère et de l'Enfant Lagune, Cotonou, 01 BP 107, Benin. .
Meremikwu M; Institute of Tropical Disease Research and Prevention, University of Calabar Teaching Hospital, Calabar, PMB 1278, Nigeria. .
Tshefu A; Kinshasa School of Public Health, University of Kinshasa, 11850, Kinshasa, Democratic Republic of Congo. .
Ogutu B; Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. .
Ouedraogo A; Centre National de Recherche et de Formation sur le Paludisme, Ministère de la Santé, 01 BP 2208, Ouagadougou, Burkina Faso. .
Lingani M; Unité de Recherche Clinique de Nanoro (IRSS-CRUN), BP 218, Ouagadougou, CMS11, Burkina Faso. .
Cousin M; Novartis Pharma AG, CH-4002, Basel, Switzerland. .
Lefèvre G; Novartis Pharma AG, CH-4002, Basel, Switzerland. .
Jain JP; Novartis Healthcare Private Limited, Hyderabad, India. jay_.
Duparc S; Medicines for Malaria Venture (MMV), Route de Pré-Bois 20, 1215, Meyrin, Switzerland. .
Hamed K; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936-1080, USA. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2015 Apr 15; Vol. 14, pp. 157. Date of Electronic Publication: 2015 Apr 15.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials/*pharmacokinetics
Artemisinins/*pharmacokinetics
Ethanolamines/*pharmacokinetics
Fluorenes/*pharmacokinetics
Malaria, Falciparum/*drug therapy
Antimalarials/administration & dosage ; Antimalarials/adverse effects ; Artemether, Lumefantrine Drug Combination ; Artemisinins/administration & dosage ; Artemisinins/adverse effects ; Drug Combinations ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Ethanolamines/administration & dosage ; Ethanolamines/adverse effects ; Female ; Fluorenes/administration & dosage ; Fluorenes/adverse effects ; Humans ; Infant ; Male ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 218

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies